Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (221-230 of 281) with videos related to

Pageof 29
Sort By:
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Rheumatology (Oxford, England)|December 15, 2010
Registries in systemic sclerosis: a worldwide experienceFelice Galluccio, Ulrich A Walker, Svetlana Nihtyanova, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
The Journal of Rheumatology|April 3, 2017
Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic SclerosisCarolina Mejia Otero, Shervin Assassi, Marie Hudson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus MethodologyEmily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
Science Translational Medicine|December 15, 2017
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosisDavid Lagares, Alba Santos, Paula E Grasberger, et al.
Clinical Rheumatology|June 16, 2007
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritisMittermayer Santiago, Murray Baron, Kiyomitsu Miyachi, et al.
The Lancet. Rheumatology|November 8, 2023
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux diseaseMichael Hughes, Yannick Allanore, Murray Baron, et al.
Arthritis and Rheumatism|March 4, 2008
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritisMurray Baron, Orit Schieir, Marie Hudson, et al.
Arthritis Care & Research|December 1, 2015
Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort StudyKira E Riehm, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Pageof 29

Showing results (221-230 of 281) with videos related to

Sort By:
Pageof 29
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Rheumatology (Oxford, England)|December 15, 2010
Registries in systemic sclerosis: a worldwide experienceFelice Galluccio, Ulrich A Walker, Svetlana Nihtyanova, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
The Journal of Rheumatology|April 3, 2017
Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic SclerosisCarolina Mejia Otero, Shervin Assassi, Marie Hudson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus MethodologyEmily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
Science Translational Medicine|December 15, 2017
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosisDavid Lagares, Alba Santos, Paula E Grasberger, et al.
Clinical Rheumatology|June 16, 2007
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritisMittermayer Santiago, Murray Baron, Kiyomitsu Miyachi, et al.
The Lancet. Rheumatology|November 8, 2023
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux diseaseMichael Hughes, Yannick Allanore, Murray Baron, et al.
Arthritis and Rheumatism|March 4, 2008
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritisMurray Baron, Orit Schieir, Marie Hudson, et al.
Arthritis Care & Research|December 1, 2015
Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort StudyKira E Riehm, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Pageof 29